Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia

    In recent years, the development of adjunctive therapeutic hyperthermia for cancer therapy has received considerable attention. However, the mechanisms underlying hyperthermia resistance are still poorly under...

    Tao-Yan Lin, Jun-Shuang Jia, Wei-Ren Luo in Journal of Experimental & Clinical Cancer … (2024)

  2. Article

    Open Access

    The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis

    Hepatocellular carcinoma (HCC) generally arises from a background of liver cirrhosis (LC). Patients with cirrhosis and suspected HCC are recommended to undergo serum biomarker tests and imaging diagnostic eval...

    Tong Wu, Rong Fan, Jian Bai, Zhao Yang, Yun-Song Qian in Journal of Hematology & Oncology (2023)

  3. Article

    Open Access

    Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis

    Despite limited efficacy of immunotherapy for advanced non-small-cell lung cancer (NSCLC) with driver mutations, whether neoadjuvant immunotherapy could be clinically valuable in those patients warrants furthe...

    Chao Zhang, Hua-Fei Chen, Shi Yan, Lin Wu, Li-Xu Yan in npj Precision Oncology (2022)

  4. Article

    Open Access

    Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection

    Colorectal cancer liver metastasis (CRLM) is a determining factor affecting the survival of colorectal cancer (CRC) patients. This study aims at develo** a novel prognostic stratification tool for CRLM resec...

    Long Bai MD, **ao-Luan Yan MD, Yun-**n Lu MD, Qi Meng MD in Annals of Surgical Oncology (2022)

  5. No Access

    Article

    Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study

    Background. Central nervous system lymphoma (CNSL) is an aggressive lymphoma. Orelabrutinib, an oral Bruton tyrosine kinase inhibitor, is a new treatment strategy for CNSL. This study aims to evaluate the efficac...

    **g-**g Wu, Wen-Hua Wang, Meng Dong, Shan-Shan Ma in Investigational New Drugs (2022)

  6. No Access

    Article

    PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer

    PLK1 and Smad4 are two important factors in prostate cancer initiation and progression. They have been reported to play the opposite role in Pten-deleted mice, one is an oncogene, the other is a tumor suppress...

    ** Gao, **g-Lan Hao, Qian-Wen **e, Gui-Qin Han, Bin-Bing Xu, Hang Hu in Oncogene (2022)

  7. Article

    Open Access

    Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion

    Ischemic stroke represents a significant danger to human beings, especially the elderly. Interventions are only available to remove the clot, and the mechanism of neuronal death during ischemic stroke is still...

    Qing-zhang Tuo, Yu Liu, in Signal Transduction and Targeted Therapy (2022)

  8. Article

    Open Access

    Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains

    DDP-based chemotherapy is one of the first-line treatment in GC. However, the therapeutic efficacy of DDP is limited due to side effects. Therefore, it is of great significance to develop novel adjuvants to sy...

    Yao Lv, Chu-di Zhang, Yi-long Wang, Dong-ming Zhou, Meng-ying Zhu in Gastric Cancer (2021)

  9. Article

    Open Access

    Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial

    It’s a challenge for detecting the therapeutic targets of a polypharmacological drug from variations in the responsed networks in the differentiated populations with complex diseases, as stable coronary heart ...

    Jun Liu, Dan-Dan Li, Wei Dong, Yu-Qi Liu in Signal Transduction and Targeted Therapy (2021)

  10. Article

    Open Access

    Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy

    Pancreatic ductal adenocarcinoma (PDAC) is a leading causes of cancer mortality worldwide. Currently, laparoscopic pancreatic resection (LPR) is extensively applied to treat benign and low-grade diseases relat...

    Ke Chen, Yu Pan, Chao-jie Huang, Qi-long Chen, Ren-chao Zhang, Miao-zun Zhang in BMC Cancer (2021)

  11. Article

    Open Access

    PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer

    Arginine methylation is an important posttranslational modification catalyzed by protein arginine methyltransferases (PRMTs). However, the role of PRMTs in colorectal cancer (CRC) progression is not well under...

    **n-Ke Yin, Yun-Long Wang, Fei Wang, Wei-**ng Feng, Shao-Mei Bai, Wan-Wen Zhao in Oncogene (2021)

  12. Article

    Open Access

    VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment

    The acidic tumor microenvironment provides an energy source driving malignant tumor progression. Adaptation of cells to an acidic environment leads to the emergence of cancer stem cells. The expression of the ...

    Pei-Shan Hu, Ting Li, **-Fei Lin in Signal Transduction and Targeted Therapy (2020)

  13. Article

    Open Access

    Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy

    How to protect the ovarian function during radiotherapy is uncertain. The purpose of this study was to explore the association between the location of the transposed ovary and the ovarian dose in patients with...

    **ao-juan Lv, **ao-long Cheng, Ye-qiang Tu, Ding-ding Yan, Qiu Tang in Radiation Oncology (2019)

  14. Article

    Open Access

    Role of TGFβ3-Smads-Sp1 axis in DcR3-mediated immune escape of hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is a leading cause of tumour-associated mortality worldwide, but no significant improvement in treating HCC has been reported with currently available systemic therapies. Immunot...

    Hui-fang Zhu, Yan-** Liu, Ding-li Liu, Yi-dan Ma, Zhi-yan Hu in Oncogenesis (2019)

  15. No Access

    Article

    Inflammation–nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma

    Various inflammation-based prognostic scores have been associated with poor survival in patients with hepatocellular carcinoma (HCC).

    **ao-Chun Ni, Jie Xu, Yong Yi, Yi-Peng Fu in International Journal of Clinical Oncology (2019)

  16. No Access

    Article

    Myeloid cell-like transcript 2 is related to liver inflammation and the pathogenesis of hepatitis B via the involvement of CD8+T cell activation

    This study analysed the biological significance of TLT-2 on CD8+T cells in hepatitis B patients and provided a theoretical basis for the potential role of TLT-2 as an immune regulator. Flow cytometry sorting, iso...

    Jun-Chi Xu, Fei Gao, Yi-An Liu, **ao-Long Zhang in Clinical and Experimental Medicine (2019)

  17. Article

    Open Access

    Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation

    This work aims to assess the feasibility of selectively sparing the hippocampus during prophylactic cranial irradiation (PCI) for small cell lung cancer (SCLC).

    Lei Zhao, Yan Shen, **-Dong Guo, Heng-Le Gu, Wen Yu, Jia-Ming Wang in Radiation Oncology (2017)

  18. Article

    Open Access

    31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

    Andreas Lundqvist, Vincent van Hoef, **aonan Zhang in Journal for ImmunoTherapy of Cancer (2016)

  19. Article

    Open Access

    31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

    Casey Ager, Matthew Reilley, Courtney Nicholas in Journal for ImmunoTherapy of Cancer (2016)

  20. Article

    Open Access

    Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer

    The expression of novel oncogenic kinase (NOK), a member of the protein tyrosine kinase (PTK) family, has been observed in several human malignancies including non-small cell lung cancer (NSCLC). However, the ...

    Peng Chen, Wei-Miao Li, Qiang Lu, Jian Wang, **ao-Long Yan, Zhi-Pei Zhang in BMC Cancer (2014)

previous disabled Page of 2